UNSPSC 51343106: Epervudine

This classification denotes a pyrimidine antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3G05PH9FAS. European Medicines Agency schedules Epervudine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06561MIG. Epervudine generally arises in the molecular formula C12H18N2O5.

UNSPSC 51343106 Epervudine is a Commodity code with minimal recent activity mapped to it in state and local procurement. The single recent opportunity explicitly tagged to this code—Seminole County, Florida's IFB60459723LAS for naloxone and drug deactivation systems—does not solicit epervudine; the mismatch suggests the code assignment reflects a data classification error rather than active procurement demand for epervudine itself. The three additional opportunities in the source (Texas HHS's direct-to-manufacturer pharmacy RFI, Tampa Fire Department medical and first aid supplies, and Minnesota's MMCAP generic pharmaceuticals RFP) involve naloxone, first-aid consumables, and generic multi-source pharmaceuticals respectively, but none reference epervudine as a line item or required product.

The Seminole County procurement, issued as an IFB with a response deadline of July 26, 2023 (note: the posted date of June 30, 2026 appears inconsistent with the 2023 deadline in the summary), seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building. This represents the only concrete recent solicitation bearing the epervudine code, though the actual goods sought do not include epervudine. State and local procurement activity under UNSPSC 51343106 appears dormant or substantially misclassified; businesses evaluating this code should verify current assignment accuracy with issuing bodies before pursuing opportunities listed under it, and should monitor for reclassification to broader pharmaceutical or emergency-response-supply families where actual demand is demonstrable.